PharmaCyte Biotech Inc (PMCB)
NASDAQ
Fin d'année 30 Avril 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -56.157 | -90.57 | -66.699 | -64.056 | -52.332 | -8.649 | -5.267 | -25.885 |
Return on Equity (%) | -60.839 | -98.571 | -75.252 | -75.565 | -60.35 | -8.776 | -5.308 | -34.358 |
Return on Invested Capital (%) | -77.59 | -130.529 | -107.176 | -109.078 | -83.711 | -9.401 | -8.097 | -12.696 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.005 | 0.002 | 0.001 | 0.001 | 0.31 | 2.954 | 2.587 | 2.236 |
Earnings Per Share | -0.005 | -0.007 | -0.003 | -0.002 | -0.351 | -0.145 | -0.162 | -1.015 |
Cash Per Share | 0.004 | 0.001 | N/A | 0.001 | 0.218 | 2.921 | 2.546 | 2.955 |
Working Capital Per Share | 0.003 | 0.001 | N/A | N/A | 0.153 | 2.9 | 2.528 | 2.534 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.005 | -0.007 | -0.003 | -0.002 | -0.351 | -0.145 | -0.162 | 0.02 |
EBITDA Per Share | -0.005 | -0.007 | -0.003 | -0.002 | -0.351 | -0.145 | -0.162 | 0.02 |
Free Cash Flow Per Share | -0.005 | -0.007 | -0.003 | -0.002 | -0.351 | -0.145 | -0.162 | -1.015 |
Fin d'année 30 Avril 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 905,35M | 1,01B | 1,19B | 1,64B | 1,59M | 20,72M | N/A | N/A |
Fin d'année 30 Avril 2024 | Jan 2023 | Avr 2023 | Juil 2023 | Oct 2023 | Jan 2024 | Avr 2024 | Juil 2024 | Oct 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 18,21M | N/A | 8,78M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 11,08M |
Ratio cours/bénéfice | -0,64 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 0,22 |
Ratio prix/valeur comptable | 0,28 |
Rendement de dividende | - |
Actions en circulation | 6,97M |
Volume moyen (1 semaine) | 13,89k |
Volume moyen (1 mois) | 12,46k |
Variation sur 52 semaines | -26,39% |
Plus haut sur 52 semaines | 2,58 |
Plus bas sur 52 semaines | 1,39 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales